Colon cancer
It is a common malignant tumor of the digestive tract, ranking second among gastrointestinal tumors. The most common sites are the rectum and the junction of the rectum and the sigmoid colon, accounting for 60%. The disease usually occurs after the age of 40, with a male to female ratio of 2:1.
-
Site of disease:
intestinal -
Infectious :
Not contagious -
Frequent population:
It is more common in middle-aged and elderly people, 30 to 69 years old... -
Related symptoms:
Constipation with severe abdominal pain Retrograde spread of cancer cells Blood in the stool Feeling of defecation Blood in the stool and blood mixed with feces -
Concurrent disease:
Related Drugs
Compound fluorouracil oral solution
Indication: Used for the treatment of digestive tract cancer (colon cancer, rectal cancer, gastric cancer), breast cancer, primary liver cancer and other cancers.
Compound fluorouracil oral solution
Indication: Used for the treatment of digestive tract cancer (colon cancer, rectal cancer, gastric cancer), breast cancer, primary liver cancer and other cancers.
Manufacturer:
Heilongjiang Ruige Pharmaceutical Co., Ltd.
Compound fluorouracil oral solution
Indication: Used for the treatment of digestive tract cancer (colon cancer, rectal cancer, gastric cancer), breast cancer, primary liver cancer and other cancers.
Compound fluorouracil oral solution
Indication: Used for the treatment of digestive tract cancer (colon cancer, rectal cancer, gastric cancer), breast cancer, primary liver cancer and other cancers.
Manufacturer:
China Resources Sanjiu (Tangshan) Pharmaceutical Co., Ltd.
Compound fluorouracil oral solution
Indication: Used for the treatment of digestive tract cancer (colon cancer, rectal cancer, gastric cancer), breast cancer, primary liver cancer and other cancers.
Manufacturer:
North China Pharmaceutical Company.Ltd
Oxaliplatin
Indication: Combined with 5-fluorouracil and folinic acid (leucovorin): first-line treatment of metastatic colorectal cancer; adjuvant treatment of stage III (Duke’s C) colon cancer after complete resection of the primary tumor. This indication is based on the results of foreign clinical studies.
Manufacturer:
Shenzhen Neptunus Pharmaceutical Co., Ltd.
Oxaliplatin
Indication: Combined with 5-fluorouracil and folinic acid (leucovorin): first-line treatment of metastatic colorectal cancer; adjuvant treatment of stage III (Duke’s C) colon cancer after complete resection of the primary tumor. This indication is based on the results of foreign clinical studies.
Manufacturer:
Simcere Pharmaceutical Co., Ltd.
Compound fluorouracil injection
Indication: Used for the treatment of digestive tract cancer (colon cancer, rectal cancer, gastric cancer), breast cancer, primary liver cancer and other cancers.
Compound fluorouracil injection
Indication: Used for the treatment of digestive tract cancer (colon cancer, rectal cancer, gastric cancer), breast cancer, primary liver cancer and other cancers.
Manufacturer:
Shenyang Yaoda Leiyunshang Pharmaceutical Co., Ltd.
Oxaliplatin for injection
Indication: It can be used alone or in combination with fluorouracil for patients with colorectal cancer metastasis who have failed treatment with fluorouracil.
Manufacturer:
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Related Ingredients